Well, if the combined company of MDT and STJ can gain mkt share from the struggling BSX, why not? BSX overpayed but MDT can get stj cheaper for $40 or so. Assimilate some of the better products from Stj and gain at the cost of BSX, spin off and sell to JnJ.
Reg. ER, MDT will see a healthy rebound to 45s before/after the earnings. 42-43s will be the support.